COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- COVID-19 lockdown impact on Tunisian consumer behaviors and awareness related to food consumption and wastage during celebrations: Case of study “Ramadan month”
- Inactivation of E. faecalis under microwave heat treatment and ultrasound probe
- Impact of deep-fat frying cycles on the physicochemical characteristics of two edible vegetable oils marketed in Algeria
- Effect of incorporating Lippia javanica (Zumbani) on physical, nutritional, microbiological, and sensory properties of instant soup mix powder
- Exploring the Antioxidant Potential and HPLC Profile of Fenugreek (Trigonella foenum-graecum L.) Seed Extracts
- Advantages and Drawbacks of Plant-Based Beverages as Alternatives to Animal Milk: A Multidimensional Review
- The Impact of Outdoor Grazing on Launaea taraxacifolia on the Nutritional Profile, Fatty Acid Composition, and Sensory Attributes of Goliath Chicken Meat in Benin
- Acceptance of salt reduction in bakery bread among Moroccan consumers
You may also start an advanced similarity search for this article.
NAJFNR is licensed under